Vector Science & Therapeutics Appoints Darryl Drake Jr. as President of Valor

Vector Science & Therapeutics Corp. (TSXV: PAIN) today announced the appointment of Darryl Drake Jr. as President of Valor and Chairman of the Athletic Board of Directors. Valor is a newly formed ...

Vector Science & Therapeutics Corp. Grants Options as Company Advances Growth Strategy

Vector Science & Therapeutics (TSXV: PAIN) ("Vector" or the "Company") today announced that the Board of Directors has approved the grant of 206,610 stock options (the "Options") to certain directors ...
The Scientist

Showcasing the Importance of Molecular Testing for Vector-Borne Diseases

The epidemiology of known vector-borne pathogens is changing as common vectors move to new locations. Scientists seek novel strategies for mitigating public health risks and healthcare system burdens.
Business Wire

VectorBuilder’s Chief Scientist, Dr. Bruce Lahn Named to the 2024 PharmaVoice 100

CHICAGO--(BUSINESS WIRE)--VectorBuilder, a global leader in gene delivery solutions, announced today that its Chief Scientist, Dr. Bruce Lahn, has been honored as a PharmaVoice 100 winner. This ...
The Scientist

Content by VectorBuilder

VectorBuilder – a global leader in vector design, optimization and GMP manufacturing – has formed a worldwide strategic partnership with Univercells Technologies, a provider of novel biomanufacturing ...